Top of page

Corporate

Practice

Filters

ADC Therapeutics $267 million IPO

Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which…

PPG $300 million notes offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a…

PPG $300 million notes offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a…

Xilinx $750 million notes offering

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Xilinx,…
Back to top